OpenAlex
PricingAboutJobs
Log inGet started
Work

Abstract P4-14-13: Pertuzumab (P) use in first-line HER2-positive metastatic breast cancer (mBC) in US community oncology practices: Treatment patterns and outcomes

HTML

Year: 2016
Type: conference-abstract
Source: Cancer Research
DOI: 10.1158/1538-7445.sabcs15-p4-14-13
Authors: N Robert, H-P Goertz, L Asmar, W-Y Tseng, X Jiao, C Portera, B Yoo, D Patt, V Antao
Institution: Genentech
Language: English

Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: pertuzumab, HER2-positive metastatic breast cancer, first-line therapy, trastuzumab, docetaxel, treatment patterns, adverse events, progression-free survival, community oncology practice, real-world outcomes, peripheral neuropathy, neutropenia, rash, diarrhea, fatigue, hormone receptor-positive breast cancer, breast cancer recurrence, de novo metastatic breast cancer
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2395037535
Cites:
Cited by: 4
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security